DCPH - Deciphera Pharmaceuticals GAAP EPS of -$0.80 beats by $0.05 revenue of $29.2M beats by $2.03M May, 04 2022 07:13 AM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals press release (NASDAQ:DCPH): Q1 GAAP EPS of -$0.80 beats by $0.05. Revenue of $29.2M (+15.9% Y/Y) beats by $2.03M. For further details see: Deciphera Pharmaceuticals GAAP EPS of -$0.80 beats by $0.05, revenue of $29.2M beats by $2.03M